Wei-Nan Li Selected Research

Wei-Nan Li Research Topics

3	Neoplasms (Cancer) 01/2018 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2019
2	Reperfusion Injury 01/2019 - 01/2019
1	Liver Neoplasms (Liver Cancer) 07/2021
1	Fibrosis (Cirrhosis) 10/2020
1	Inflammation (Inflammations) 10/2020
1	Ureteral Obstruction 10/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Infections 01/2018
1	Deficiency Diseases (Deficiency Disease) 01/2018
1	Squamous Intraepithelial Lesions 01/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018
1	Heart Injuries 01/2018
1	Persistent Infection 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017
1	Thyroid Neoplasms (Thyroid Cancer) 09/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015
1	Pleural Effusion (Pleural Effusions) 01/2012
1	Adenocarcinoma 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Lung Diseases (Lung Disease) 01/2012
1	Neoplasm Micrometastasis 01/2012

2	Messenger RNA (mRNA)IBA 01/2018 - 01/2012
2	CateninsIBA 09/2015 - 01/2012
1	Metal-Organic FrameworksIBA 07/2021
1	norcantharidinIBA 07/2021
1	shenkangIBA 10/2020
1	pentifyllineIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	HMGB1 Protein (HMG1)IBA 01/2019
1	Huang QiIBA 01/2019
1	mangiferinIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	danggui buxue decoctionIBA 01/2018
1	PlasticsIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Cyclin D1IBA 09/2015

2	Ligation 01/2019 - 01/2019
1	Aftercare (After-Treatment) 10/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2020